510(k) device
gammaCore-S
Electrocore, LLC · Non-Invasive Vagus Nerve Stimulator - Headache (PKR, Class II) · First FDA decision May 30, 2017, newest Jan 23, 2018Migraine and headache
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
4
Naming "gammaCore-S"
MAUDE reports
1
Brand "gammaCore-S", since 2015
PubMed studies
0
Mentioning "gammaCore-S"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing gammaCore-S
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- gammaCore-S510(k)
K173442 · Decided Jan 23, 2018 · 78 days after receipt
Device type: Non-Invasive Vagus Nerve Stimulator - Headache (PKR) · Neurology & Neurosurgery
1 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Vagus Nerve Stimulation (VNS)National determinationOn the books160.18Updated Nov 5, 2026
- Vagus Nerve Stimulation for Treatment of Resistant Depression (TRD)National analysisReview closedCAG-00313RUpdated Sep 24, 2026
- Vagus Nerve Stimulation (VNS) for Treatment Resistant Depression (TRD)National analysisReview closedCAG-00313R2Updated Sep 24, 2026
- Transcutaneous Electrical Nerve Stimulators (TENS) - RETIREDNational determinationOn the books280.13Updated Jun 7, 2024
- Electrical Nerve StimulatorsNational determinationOn the books160.7Updated Aug 17, 2023
- Phrenic Nerve StimulatorNational determinationOn the books160.19Updated Jun 12, 2020
- Transcutaneous Electrical Nerve Stimulators (TENS)Local determinationIn effectL33802CGS Administrators, LLCUpdated Dec 7, 2023
Clinical trials
Device studies on ClinicalTrials.gov that name "gammaCore-S", any status and sponsor, newest update first.
Mayo ClinicAcademic, hospital or other
NCT06268288 · 40 participants · Start Feb 14, 2024 · Primary completion Oct 5, 2024
Device: GammaCore intervention · For: Postural Tachycardia Syndrome; Autonomic Dysfunction; Postural Orthostatic Tachycardia Syndrome and 1 more
Sites: Rochester, Minnesota · 2 sites in all
3 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "gammaCore-S", and for the whole product code for context.
This brand
1 reports: 0 malfunction, 1 injury, 0 death
Whole product code PKR
1 reports: 0 malfunction, 1 injury, 0 death
Newest reports for this brand
- GAMMACORE-S UNITInjury
3009060963-2018-00001 · Received Oct 24, 2018 · Event dated Sep 12, 2018
Device type: Non-Invasive Vagus Nerve Stimulator - Headache (PKR)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Swollen Lymph Nodes; Twitching; Numbness; Ambulation or Postural Difficulties
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "gammaCore-S"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code PKR.
- gammaCore SapphireElectrocore, Inc. · 510(k) 2021
- gammaCore-2Eletrocore, LLC · 510(k) 2017
- gammaCore Non-invasive Vagus Nerve StimulatorElectrocore, LLC · De Novo 2017
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.